phosphatidylserine liposomal
Selected indexed studies
- Improving outcomes in intracerebral hemorrhage through microglia/macrophage-targeted IL-10 delivery with phosphatidylserine liposomes. (Biomaterials, 2023) [PMID:37597297]
- Transferrin-phosphatidylserine liposomes target TDP-43 and neuroinflammation in male mice with neuropathic pain. (Nat Commun, 2025) [PMID:41387431]
- Antibodies to liposomal phosphatidylserine and phosphatidic acid. (Biochem Cell Biol, 1990) [PMID:2190623]
_Worker-drafted node — pending editorial review._
Connections
phosphatidylserine liposomal helps
phosphatidylserine liposomal protects against
Sources
- Improving outcomes in intracerebral hemorrhage through microglia/macrophage-targeted IL-10 delivery with phosphatidylserine liposomes. (2023) pubmed
- Transferrin-phosphatidylserine liposomes target TDP-43 and neuroinflammation in male mice with neuropathic pain. (2025) pubmed
- Antibodies to liposomal phosphatidylserine and phosphatidic acid. (1990) pubmed
- Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice. (2025) pubmed
- Liposome opsonization. (2005) pubmed
- Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice. (2014) pubmed
- Inhibition of c-Rel expression in myeloid and lymphoid cells with distearoyl -phosphatidylserine (DSPS) liposomal nanoparticles encapsulating therapeutic siRNA. (2022) pubmed
- A phosphatidylserine-targeted self-amplifying nanosystem improves tumor accumulation and enables efficient tumor therapy by modulating anticancer immunity. (2026) pubmed
- Liposomal encapsulation enhances in vivo near infrared imaging of exposed phosphatidylserine in a mouse glioma model. (2013) pubmed
- Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide. (1996) pubmed